Transperineal MR Imaging–Guided Prostate Biopsy: A Prospective Randomized Controlled Study on Safety and Effectiveness Compared with Transrectal Biopsy
🔍 **Clinical Question:**
Is magnetic resonance (MR) imaging–guided in-bore transperineal prostate biopsies (TP-Bx) safe and tolerable?
Adverse events occurred in 8.9% of patients undergoing transrectal prostate biopsy and 4.4% of patients undergoing transperineal prostate biopsy, with no significant difference between groups. Transperineal approach demonstrated a higher cancer detection rate (42.5%) than transrectal approach (28.2%) and a significantly higher clinically significant cancer detection rate (27.5% vs 7.7%, P = .019).
Quality-of-life and pain assessments showed no significant differences between groups, although changes in management were more frequent following transperineal prostate biopsy (32.5% vs 15.4%, P = .050).
Post author
Annie Phan
MS4 Medical Student
University of Massachusetts Chan Medical School
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.